News search

E.g., 19/06/2026
E.g., 19/06/2026
About the CNIC
11 Jun 2026

The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease

COMPASS
About the CNIC
31 Mar 2026

The initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors 

Foto
Research
5 Feb 2026

prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction.

Equipo del CNIC
Research
2 Feb 2026

A team from the CNIC and Hospital Clínico Universitario de Valladolid has developed a minimally invasive, catheter-based procedure to treat defective mechanical aortic valves

Research
14 Jan 2026

A CNIC research team has identified for the first time the biological mechanism underlying this susceptibility: high blood pressure creates a hidden metabolic vulnerability in the heart that becomes destabilized when anthracyclines are administered.

Edgar Gomes
JACARDI_Madrid
About the CNIC
20 Oct 2025

The Spanish National Center for Cardiovascular Research (CNIC) hosted in Madrid the third General Assembly of JACARDI from October 14 to 16 

José Luis de la Pompa, Blanca Rubio, Rocío Serrano, Laura Lalaguna, Pablo García Pavía, María López Olañeta y Enrique Lara.
Research
10 Sep 2025

The results, published in the European Heart Journal and presented at the European Society of Cardiology Congress, opens the way to new therapies for patients with genetic heart diseases

Pablo García-Pavía, Nerea Mora Ayestarán y Fernando Domínguez
Research
3 Sep 2025

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), together with cardiologists from Hospital Universitario Puerta de Hierro and the Spanish cardiovascular disease research network (CIBERCV), report that the new discovery makes it possible to identify high-risk patients early and refer them sooner to specialized heart failure units